DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$72.1M |
| 2 |
Indivior
INDV
|
$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$45.7M |
| 4 |
Merus
MRUS
|
$32.9M |
| 5 |
Viatris
VTRS
|
$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$102M |
| 2 |
Surgery Partners
SGRY
|
$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
$57.6M |
| 4 |
BioNTech
BNTX
|
$49.8M |
| 5 |
Integra LifeSciences
IART
|
$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
FMC
FMC
$4.72B
| $513K | 0.01% |
7,775
-458
| -6% | -$30.2K |
|
277
Arrowhead Research
ARWR
$4.02B
| $512K | 0.01% |
26,439
+6,978
| +36% | +$135K |
|
278
IAC Inc
IAC
$2.98B
| $509K | 0.01% |
11,526
-4,739
| -29% | -$209K |
|
279
Graham Holdings Company
GHC
$4.93B
| $507K | 0.01% |
+617
| New | +$507K |
|
280
Albemarle
ALB
$9.6B
| $506K | 0.01% |
5,342
-847
| -14% | -$80.2K |
|
281
Select Medical
SEM
$1.62B
| $505K | 0.01% |
+26,869
| New | +$505K |
|
282
Palomar
PLMR
$3.3B
| $501K | 0.01% |
+5,292
| New | +$501K |
|
283
SentinelOne
S
$6.25B
| $500K | 0.01% |
+20,911
| New | +$500K |
|
284
DexCom
DXCM
$31.6B
| $495K | 0.01% |
+7,391
| New | +$495K |
|
285
Stride
LRN
$7.01B
| $490K | 0.01% |
+5,746
| New | +$490K |
|
286
OrthoPediatrics
KIDS
$524M
| $485K | 0.01% |
17,897
+10,825
| +153% | +$293K |
|
287
Castle Biosciences
CSTL
$683M
| $483K | 0.01% |
16,943
-857,666
| -98% | -$24.5M |
|
288
Molson Coors Class B
TAP
$9.96B
| $478K | 0.01% |
+8,316
| New | +$478K |
|
289
Protolabs
PRLB
$1.19B
| $476K | 0.01% |
16,210
-2,909
| -15% | -$85.4K |
|
290
CrowdStrike
CRWD
$105B
| $476K | 0.01% |
+1,696
| New | +$476K |
|
291
Boeing
BA
$174B
| $475K | 0.01% |
3,123
+45
| +1% | +$6.84K |
|
292
Fulgent Genetics
FLGT
$672M
| $471K | 0.01% |
+21,690
| New | +$471K |
|
293
Sun Communities
SUI
$16.2B
| $471K | 0.01% |
+3,486
| New | +$471K |
|
294
ADT
ADT
$7.13B
| $468K | 0.01% |
+64,748
| New | +$468K |
|
295
The RMR Group
RMR
$284M
| $461K | 0.01% |
+18,170
| New | +$461K |
|
296
TriNet
TNET
$3.43B
| $460K | 0.01% |
+4,744
| New | +$460K |
|
297
Lifestance Health
LFST
$2.09B
| $454K | 0.01% |
+64,787
| New | +$454K |
|
298
Teledyne Technologies
TDY
$25.7B
| $450K | 0.01% |
1,028
-2,628
| -72% | -$1.15M |
|
299
Old Republic International
ORI
$10.1B
| $448K | 0.01% |
+12,645
| New | +$448K |
|
300
Civitas Resources
CIVI
$3.19B
| $446K | 0.01% |
8,805
+5,180
| +143% | +$262K |
|